Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages.
Manara MC, Manferdini C, Cristalli C, Carrabotta M, Santi S, De Feo A, Caldoni G, Pasello M, Landuzzi L, Lollini PL, Salamanna F, Dominici S, Fiori V, Magnani M, Lisignoli G, Scotlandi K. Manara MC, et al. Among authors: pasello m. Cancer Immunol Res. 2024 Feb 2;12(2):247-260. doi: 10.1158/2326-6066.CIR-23-0440. Cancer Immunol Res. 2024. PMID: 38051221 Free PMC article.
CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin.
Guerzoni C, Fiori V, Terracciano M, Manara MC, Moricoli D, Pasello M, Sciandra M, Nicoletti G, Gellini M, Dominici S, Chiodoni C, Fornasari PM, Lollini PL, Colombo MP, Picci P, Cianfriglia M, Magnani M, Scotlandi K. Guerzoni C, et al. Among authors: pasello m. Clin Cancer Res. 2015 Jan 1;21(1):146-56. doi: 10.1158/1078-0432.CCR-14-0492. Epub 2014 Dec 11. Clin Cancer Res. 2015. PMID: 25501132
Process development of a human recombinant diabody expressed in E. coli: engagement of CD99-induced apoptosis for target therapy in Ewing's sarcoma.
Moricoli D, Carbonella DC, Dominici S, Fiori V, Balducci MC, Guerzoni C, Manara MC, Pasello M, Laguardia ME, Cianfriglia M, Scotlandi K, Magnani M. Moricoli D, et al. Among authors: pasello m. Appl Microbiol Biotechnol. 2016 May;100(9):3949-63. doi: 10.1007/s00253-015-7226-5. Epub 2015 Dec 21. Appl Microbiol Biotechnol. 2016. PMID: 26685854
CD99 at the crossroads of physiology and pathology.
Pasello M, Manara MC, Scotlandi K. Pasello M, et al. J Cell Commun Signal. 2018 Mar;12(1):55-68. doi: 10.1007/s12079-017-0445-z. Epub 2018 Jan 6. J Cell Commun Signal. 2018. PMID: 29305692 Free PMC article. Review.
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy.
Manara MC, Valente S, Cristalli C, Nicoletti G, Landuzzi L, Zwergel C, Mazzone R, Stazi G, Arimondo PB, Pasello M, Guerzoni C, Picci P, Nanni P, Lollini PL, Mai A, Scotlandi K. Manara MC, et al. Among authors: pasello m. Mol Cancer Ther. 2018 Sep;17(9):1881-1892. doi: 10.1158/1535-7163.MCT-17-0818. Epub 2018 Jun 29. Mol Cancer Ther. 2018. PMID: 29959201
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations.
Nanni P, Landuzzi L, Manara MC, Righi A, Nicoletti G, Cristalli C, Pasello M, Parra A, Carrabotta M, Ferracin M, Palladini A, Ianzano ML, Giusti V, Ruzzi F, Magnani M, Donati DM, Picci P, Lollini PL, Scotlandi K. Nanni P, et al. Among authors: pasello m. Sci Rep. 2019 Aug 21;9(1):12174. doi: 10.1038/s41598-019-48634-y. Sci Rep. 2019. PMID: 31434953 Free PMC article.
ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
Zucchini C, Manara MC, Cristalli C, Carrabotta M, Greco S, Pinca RS, Ferrari C, Landuzzi L, Pasello M, Lollini PL, Gambarotti M, Donati DM, Scotlandi K. Zucchini C, et al. Among authors: pasello m. J Exp Clin Cancer Res. 2019 Dec 26;38(1):503. doi: 10.1186/s13046-019-1506-3. J Exp Clin Cancer Res. 2019. PMID: 31878963 Free PMC article.
Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity.
Balestra T, Manara MC, Laginestra MA, Pasello M, De Feo A, Bassi C, Guerzoni C, Landuzzi L, Lollini PL, Donati DM, Negrini M, Magnani M, Scotlandi K. Balestra T, et al. Among authors: pasello m. Mol Cancer Ther. 2022 Jan;21(1):58-69. doi: 10.1158/1535-7163.MCT-21-0189. Epub 2021 Oct 19. Mol Cancer Ther. 2022. PMID: 34667115
43 results